Skip to main content

Table 1 Clinical characteristics of CAP and CAP-T2DM patients

From: The incremental value of aspartate aminotransferase/alanine aminotransferase ratio combined with CURB-65 in predicting treatment outcomes in hospitalized adult community-acquired pneumonia patients with type 2 diabetes mellitus

Variables

CAP

n = 540

CAP-T2DM

N = 180

p value

Gender (male %)

341 (63.1)

111 (61.7)

0.723

Age (years)

72.00 (62.00, 79.00)

72.00 (63.00, 78.00)

0.587

Comorbidities, n (%)

 Hypertension

191 (35.4)

67 (37.2)

0.655

 Chronic Cardiovascular Diseases

127 (23.5)

44 (24.4)

0.840

 Chronic Pulmonary Diseases

51 ( 9.4)

21 (11.7)

0.391

 Chronic Cerebrovascular Diseases

83 (15.4)

31 (17.2)

0.557

 Chronic Hepatic Diseases

12 ( 2.2)

6 ( 3.3)

0.413

 Chronic Renal Diseases

17 ( 3.1)

7 ( 3.9)

0.634

 Cancer

27 ( 5.0)

11 ( 6.1)

0.566

Complete blood count

 WBC (× 109/L)

7.80 (5.80, 11.70)

8.90 (6.50, 13.02)

0.006

 NEU (× 109/L)

6.15 (4.10, 10.01)

7.12 (4.92, 10.79)

0.007

 LYM (× 109/L)

0.94 (0.60, 1.40)

1.21 (0.71, 1.76)

0.001

 PLT (× 109/L)

180.00 (130.00, 252.00)

186.50 (135.00, 251.75)

0.364

 HB (g/L)

120.00 (106.00, 131.50)

117.00 (101.00, 133.00)

0.376

 NLR

6.66 (3.33, 13.71)

6.40 (3.73, 11.87)

0.776

 PLR

200.23 (121.28, 323.08)

162.18 (104.29, 294.09)

0.022

Infection and inflammation

 ESR (mm/h)

45.00 (21.00, 72.50)

56.00 (27.00, 89.50)

0.059

 PCT (ug/L)

0.17 (0.10, 0.84)

0.18 (0.10, 0.83)

0.470

 CRP (mg/L)

36.74 (8.96, 104.38)

37.03 (8.00, 110.82)

0.947

Blood glucose condition

 GLU (mmol/L)

5.77 (5.02, 7.09)

10.33 (7.24, 14.99)

< 0.001

 HbA1c (%)

5.90 (5.60, 6.30)

7.80 (6.80, 10.30)

< 0.001

Coagulation

 APTT (sec)

36.70 (32.30, 40.80)

34.75 (31.30, 39.30)

0.010

 FIB (g/L)

4.26 (3.26, 5.79)

4.42 (3.39, 5.79)

0.272

 PT (sec)

13.70 (12.90, 14.70)

13.80 (12.90, 14.60)

0.861

 INR

1.08 (1.02, 1.17)

1.09 (1.01, 1.17)

0.705

 TT (sec)

17.55 (16.70, 18.72)

17.60 (16.80, 18.70)

0.615

Renal function

 BUN (mmol/L)

5.76 (4.31, 8.10)

5.78 (4.44, 8.87)

0.507

 CREA (umol/L)

73.35 (59.00, 92.55)

71.70 (54.92, 97.53)

0.296

 UA (umol/L)

300.30 (229.00, 383.50)

292.60 (228.25, 376.70)

0.916

 A1MG (mg/L)

26.90 (21.50, 36.58)

31.60 (22.10, 43.55)

0.235

 B2MG (mg/L)

2.70 (1.86, 4.65)

2.69 (1.92, 4.11)

0.872

 Ca (mmol/L)

2.17 (2.07, 2.28)

2.20 (2.07, 2.31)

0.092

 Cl (mmol/L)

105.80 (103.00, 108.10)

105.00 (101.50, 108.10)

0.187

 K (mmol/L)

3.84 (3.48, 4.19)

3.94 (3.60, 4.25)

0.049

 Mg (mmol/L)

0.87 (0.80, 0.94)

0.86 (0.78, 0.93)

0.118

 Na (mmol/L)

139.10 (136.35, 141.80)

139.00 (136.00, 142.00)

0.955

 P (mmol/L)

0.97 (0.83, 1.16)

0.96 (0.82, 1.13)

0.615

Liver function

 ALT (U/L)

18.00 (11.00, 33.00)

18.00 (12.00, 30.00)

0.909

 AST (U/L)

25.00 (19.00, 38.00)

21.00 (15.00, 35.75)

0.001

 AST/ALT

1.42 (1.06, 2.00)

1.22 (0.94, 1.62)

0.001

 5’-NT (U/L)

5.10 (3.20, 8.05)

5.85 (3.30, 10.40)

0.043

 ADA (U/L)

11.90 (9.30, 16.00)

15.30 (12.12, 20.20)

< 0.001

 ALP (U/L)

84.00 (69.50, 106.00)

96.50 (75.25, 128.00)

0.001

 CHE (U/L)

5712.00 (4442.00, 7104.50)

6035.00 (4968.75, 7816.25)

0.011

 GGT (U/L)

26.00 (17.00, 56.00)

34.00 (21.25, 64.00)

0.019

 LDH (U/L)

220.00 (185.00, 288.75)

217.50 (174.00, 291.50)

0.237

 MAO (U/L)

10.40 (7.90, 14.90)

10.10 (7.18, 14.40)

0.443

 TP (g/L)

64.90 (59.90, 69.88)

65.05 (59.73, 70.70)

0.614

 PA (mg/L)

152.00 (109.50, 195.00)

152.00 (109.75, 195.00)

0.608

 ALB (g/L)

35.00 (31.20, 38.50)

34.30 (30.50, 38.55)

0.487

 GLOB (g/L)

29.35 (25.80, 32.90)

29.90 (26.20, 33.98)

0.174

 A/G

1.20 (1.00, 1.40)

1.20 (1.00, 1.40)

0.119

 TBA (umol/L)

4.30 (2.30, 7.40)

3.55 (2.20, 6.80)

0.307

 CG (mg/L)

1.70 (1.20, 2.73)

1.85 (1.30, 2.40)

0.618

 TBIL (umol/L)

11.20 (8.00, 16.10)

11.10 (6.93, 15.88)

0.470

 DBIL (umol/L)

3.40 (2.50, 5.70)

3.40 (2.30, 5.40)

0.394

Cardiac and myocardial condition

 NT-proBNP (pg/ml)

851.05 (226.22, 2554.76)

803.60 (210.90, 2891.38)

0.752

 CK-MB (U/L)

1.51 (0.99, 2.80)

1.46 (0.90, 2.63)

0.458

 Mb (ng/ml)

78.46 (44.63, 176.20)

79.39 (52.38, 170.28)

0.851

 cTnI (μg/L)

0.02 (0.00, 0.05)

0.02 (0.00, 0.06)

0.558

 CK (U/L)

95.00 (56.00, 211.00)

81.00 (45.00, 133.50)

0.023

 IMA (U/mL)

80.30 (77.00, 85.70)

80.70 (76.75, 84.35)

0.675

CURB-65 score, n (%)

 0–1

270 (50.2)

90 (50.0)

1.000

 2

185 (34.4)

58 (32.2)

0.649

 3–5

83 (15.4)

32 (17.8)

0.482

CURB-65 (points)

1.00 (1.00, 2.00)

1.50 (1.00, 2.00)

0.770

LOS (days)

6.00 (4.00, 10.00)

9.00 (6.00, 13.25)

< 0.001

  1. Data are presented as frequency (%) or as median (interquartile range)
  2. CAP community-acquired pneumonia, CAP-T2DM community-acquired pneumonia with type 2 diabetes mellitus, WBC white blood cell, NEU neutrophil, LYM lymphocyte, PLT platelet, HB hemoglobin, NLR neutrophil–lymphocyte ratio, PLR platelet-lymphocyte ratio, ESR erythrocyte sedimentation rate, PCT procalcitonin, CRP C-reactive protein, GLU glucose, HbA1c glycated hemoglobin, A1c APTT activated partial thromboplastin time, FIB fibrinogen, PT prothrombin time, INR international normalized ratio, TT thrombin time, BUN blood urea nitrogen, CREA creatinine, UA uric acid, A1MG α1-microglobulin, B2MG β2-microglobulin, Ca calcium, Cl chlorine, K potassium, Mg magnesium, Na sodium, P phosphorus, ALT alanine aminotransferase, AST aspartate aminotransferase, AST/ALT aspartate aminotransferase/alanine aminotransferase ratio, 5’-NT 5-nucleotidase, ADA adenosine deaminase, ALP alkaline phosphatase, CHE acetylcholine esterase, GGT γ-glutamyltransferase, LDH lactate dehydrogenase, MAO monoamine oxidase, TP total protein, PA prealbumin, ALB albumin, GLOB globulin, A/G albumin/globulin ratio, TBA total bile acid, CG cholyglycine, TBIL total bilirubin, DBIL direct bilirubin, NT-proBNP N-terminal prohormone of brain natriuretic peptide, CK-MB MB isoenzyme of creatine kinase, Mb myohemoglobin, cTnI cardiac troponin I, CK creatine kinase, IMA ischemia-modified albumin, LOS length of stay